Bank of America’s ESSA Pharma EPIX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.07M | Sell |
627,930
-70,338
| -10% | -$120K | ﹤0.01% | 4417 |
|
2025
Q1 | $1.1M | Sell |
698,268
-114,042
| -14% | -$180K | ﹤0.01% | 4300 |
|
2024
Q4 | $1.45M | Buy |
812,310
+812,302
| +10,153,775% | +$1.45M | ﹤0.01% | 3984 |
|
2024
Q3 | $48 | Hold |
8
| – | – | ﹤0.01% | 6911 |
|
2024
Q2 | $42 | Hold |
8
| – | – | ﹤0.01% | 6969 |
|
2024
Q1 | $68 | Hold |
8
| – | – | ﹤0.01% | 6524 |
|
2023
Q4 | $53 | Hold |
8
| – | – | ﹤0.01% | 6524 |
|
2023
Q3 | $25 | Hold |
8
| – | – | ﹤0.01% | 6626 |
|
2023
Q2 | $22 | Sell |
8
-2,162
| -100% | -$5.95K | ﹤0.01% | 6616 |
|
2023
Q1 | $6.45K | Buy |
2,170
+1,156
| +114% | +$3.43K | ﹤0.01% | 6189 |
|
2022
Q4 | $2.56K | Buy |
1,014
+1,006
| +12,575% | +$2.54K | ﹤0.01% | 6364 |
|
2022
Q3 | $0 | Sell |
8
-8,656
| -100% | – | ﹤0.01% | 6994 |
|
2022
Q2 | $27K | Sell |
8,664
-2,950
| -25% | -$9.19K | ﹤0.01% | 6272 |
|
2022
Q1 | $72K | Buy |
11,614
+3,420
| +42% | +$21.2K | ﹤0.01% | 6230 |
|
2021
Q4 | $116K | Buy |
8,194
+1,258
| +18% | +$17.8K | ﹤0.01% | 5984 |
|
2021
Q3 | $55K | Buy |
6,936
+2,917
| +73% | +$23.1K | ﹤0.01% | 6114 |
|
2021
Q2 | $115K | Buy |
4,019
+3,199
| +390% | +$91.5K | ﹤0.01% | 5654 |
|
2021
Q1 | $24K | Buy |
820
+812
| +10,150% | +$23.8K | ﹤0.01% | 6142 |
|
2020
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 6339 |
|
2020
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 6252 |
|
2020
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 6244 |
|
2020
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 6233 |
|
2019
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 6273 |
|
2019
Q3 | $0 | Buy |
+8
| New | – | ﹤0.01% | 6435 |
|
2018
Q2 | – | Sell |
-2,500
| Closed | – | – | 6362 |
|
2018
Q1 | $0 | Buy |
+2,500
| New | – | ﹤0.01% | 6336 |
|